NEUROMAMA, LTD. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-01-26: Form 8-K/A; Period of report 2016-10-12; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2017-01-19: Form 8-K; Period of report 2016-10-12; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2016-08-25: Form 8-K; Period of report 2016-08-23; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2016-08-22: Form 8-K; Period of report 2016-08-17; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-01-26 | 8-K/A | 2016-10-12 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) On October 12, 2016, the Board of Directors of Neuromama, Ltd. (the "Company") dismissed MaloneBailey, LLP (“MaloneBailey”) as the principal accountant for the Company. | nero-20170126_8ka.htm |
| 2017-01-19 | 8-K | 2016-10-12 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) On October 12, 2016, the Board of Directors of Neuromama, Ltd. (the "Company") dismissed MaloneBailey, LLP (“MaloneBailey”) as the principal accountant for the Company. | nero-20170118_8k.htm |
| 2016-08-25 | 8-K | 2016-08-23 | 7.01 Regulation FD Disclosure | 7.01 The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended. | nero-20160824_8k.htm |
| 2016-08-22 | 8-K | 2016-08-17 | 7.01 Regulation FD Disclosure | 7.01 The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended. | nero-20160818_8k.htm |
| 2016-03-10 | 8-K | 2016-02-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 29, 2016, Neuromama, Ltd. (the “Company”) accepted the resignation of Alexander Vladimirs Solovjovs Chief Operating Officer and Director of the Company. | form8k.htm |
| 2015-01-30 | 8-K | 2015-01-20 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On or about January 20, 2015, the Board of Directors of Neuromama, Ltd. (the “Company”) approved the engagement of MaloneBailey, LLP (“MaloneBailey”) as its principal accountant to audit the Company’s financial statements as successor to Silberstein Ungar, PLLC CPAs. | form8k.htm |
| 2014-09-04 | 8-K | 2014-08-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On August 12, 2014, Neuromama, Ltd. (the “Company”) received resignation notices from Alexander Vikoulov as Chief Financial Officer and Director of the Company. | form8k.htm |
| 2014-07-03 | 8-K | 2014-06-17 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) On June 17, 2014, Silberstein Ungar, PLLC CPAs (“Silberstein”), the principal accountant for Neuromama, Ltd. (the "Company") resigned as the Company’s principal accountant. | form8k.htm |
| 2014-05-06 | 8-K | 2014-05-02 | 8.01 Other Events | 8.01 Effective May 2, 2014, Neuromama, Ltd. (the “Company”) changed the location of its main corporate headquarters to the following address: Blvd. | form8k.htm |
| 2014-04-16 | 8-K | 2014-04-09 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 9, 2014, Neuromama, Ltd. (the “Company”) received resignation notices from Nataliya Peysakovich as Treasurer and Secretary of the Company. | form8k.htm |
| 2014-03-26 | 8-K | 2014-03-14 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 14, 2014, Neuromama, Ltd. (the “Company”) received resignation notices from Igor Weselovsky as Treasurer and Alexander Vikoulov as Secretary of the Company. | form8k.htm |
| 2014-03-13 | 8-K | 2014-03-12 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 3.02 On March 12, 2014, Neuromama, Ltd. (the “Company”) entered into a Financing and Services Agreement (the “Agreement”) with Global Media & Internet Company (“Global Media”). | form8k.htm |
| 2014-02-12 | 8-K | 2014-02-06 | 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders | 3.02 On February 6, 2014, Neuromama, Ltd. (the “Company”) issued 253,500 shares of Series A Preferred Stock to its President and C.E.O. Mr. Igor Weselovsky. 3.03 On February 11, 2014, the Company filed a Certificate of Designation of Series A Preferred Stock (the "Certificate of Designation”) with the Nevada Secretary of State designating 1,000,000 of the Company's previously authorized preferred stock. | form8k.htm |
| 2013-11-26 | 8-K | 2013-11-15 | 8.01 Other Events | 8.01 On November 15, 2013, Alexander Vikoulov, the Chief Financial Officer, Secretary and a Director of Neuromama, Ltd. (the “Company”) requested that the Company cancel 2,535,000,001 common shares of the Company that he owns in his own name. | form8k.htm |
| 2013-10-03 | 8-K | 2013-09-24 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 3.02 On September 24, 2013, Neuromama, Ltd. (the “Company”) entered into an Intellectual Property Purchase Agreement (the “Agreement”) with John Sterling (“Sterling”). | form8k.htm |
| 2013-07-23 | 8-K | 2013-07-15 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On July 15, 2013, Neuromama, Ltd. (the “Company”) received a resignation notice from Barbara Walaszek as Treasurer and Director of the Company. | form8k.htm |
| 2013-07-15 | 8-K/A | 2013-06-13 | 1.01 Entry into a Material Definitive Agreement; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 5.01 Changes in Control of Registrant. 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. 8.01 As a result of the acquisition of the domain name and website disclosed in Item 1.01 above, the Company has decided to change its focus to operating the NeuroMama.com search engine. | form8ka.htm |
| 2013-07-09 | 8-K | 2013-06-13 | 1.01 Entry into a Material Definitive Agreement; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 5.01 Changes in Control of Registrant. 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. 8.01 As a result of the acquisition of the domain name and website disclosed in Item 1.01 above, the Company has decided to change its focus to operating the NeuroMama.com search engine. | form8k.htm |
| 2013-06-18 | 8-K/A | 2013-06-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 12, 2013, Neuromama, Ltd. (the “Company”) received a resignation notice from Barbara Walaszek as Chief Financial Officer of the Company. | form8ka.htm |
| 2013-06-13 | 8-K | 2013-06-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 12, 2013, Neuromama, Ltd. (the “Company”) received a resignation notice from Barbara Walaszek as Secretary of the Company. | form8k.htm |
| 2013-06-05 | 8-K | 2013-05-22 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 8.01 (2) effecting a 750 for 1 forward-split of the Company’s issued and outstanding common shares. | form8k.htm |